Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hycor's arthritis test gets FDA clearance:

This article was originally published in Clinica

Executive Summary

Hycor Biomedical has received 510(k) FDA clearance to market its Rheumatoid Factor (RF) IgA ELISA autoimmune test. The test completes a series of rheumatoid arthritis tests from Hycor and complements the RF IgM and RF IgG tests previously cleared for marketing by the FDA. All tests can be performed using a manual procedure as well as in a fully automated mode on Hycor's new HYoTEC 288 automated immunoassay system, the Garden Grove, California-based company said.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT075797

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel